title: Identification of c-Yes expression in the nuclei of hepatocellular carcinoma cells: involvement in the early stages of hepatocarcinogenesis.
abstract: It is thought that the subcellular distribution of Src-family tyrosine kinases, including c-Yes binding to the cellular membrane, is membranous and/or cytoplasmic. c-Yes protein tyrosine kinase is known to be related to malignant transformation. However, the expression patterns of c-Yes in hepatocellular carcinoma (HCC) remains unknown. In the present study, we report that c-Yes is expressed not only in the membrane and cytoplasm, but also in the nuclei of cancer cells in some human HCC tissues and in a human HCC cell line. We examined the expression and localization of c-Yes in human HCC cell lines (HLE, HLF, PLC/PRF/5 and Hep 3B) by Western blotting and immunohistochemical analyses; we also examined the expression of c-Yes by immunohistochemistry and Western blotting in the tissues of various liver diseases, including 39 samples from HCC patients. We used an antibody array to detect proteins that bind to nuclear c-Yes in PLC/PRF/5 cell line. c-Yes was found to be expressed in the membranes and cytoplasm of HLE, HLF and Hep 3B HCC cells; it was also detected in the nuclei in addition to the membranes and cytoplasm of PLC/PRF/5 HCC cells. HCC with nuclear c-Yes was detected in 5 of 39 cases (13.0%), and nuclear c-Yes expression was not detected in normal, chronic hepatitis or cirrhotic livers. All HCCs with nuclear c-Yes expression were well-differentiated, small tumors at the early stages. In the PLC/PRF/5 cell line, the nuclear localization of c-Yes with cyclin-dependent kinase 1 was confirmed by a protein antibody array. In conclusion, nuclear c-Yes expression was found in cancer cells at the early stages of hepatocarcinogenesis, suggesting that nucleus-located c-Yes may be a useful marker to detect early-stage HCC.
authors.affiliation: Department of Gastroenterology and Neurology, Kagawa University School of Medicine, Miki-cho, Kita-gun, Kagawa 761-0793, Japan.
authors.forename: Takako
authors.initials: T
authors.lastname: Nonomura
authors.forename: Tsutomu
authors.initials: T
authors.lastname: Masaki
authors.forename: Asahiro
authors.initials: A
authors.lastname: Morishita
authors.forename: Gong
authors.initials: G
authors.lastname: Jian
authors.forename: Naohito
authors.initials: N
authors.lastname: Uchida
authors.forename: Takashi
authors.initials: T
authors.lastname: Himoto
authors.forename: Kunihiko
authors.initials: K
authors.lastname: Izuishi
authors.forename: Hisakazu
authors.initials: H
authors.lastname: Iwama
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Yoshiji
authors.forename: Seishiro
authors.initials: S
authors.lastname: Watanabe
authors.forename: Kazutaka
authors.initials: K
authors.lastname: Kurokohchi
authors.forename: Shigeki
authors.initials: S
authors.lastname: Kuriyama
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000912:Antibodies, Neoplasm / Q000235:genetics; D006528:Carcinoma, Hepatocellular / Q000235:genetics* / Q000473:pathology; D045744:Cell Line, Tumor; D002467:Cell Nucleus / Q000473:pathology; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008113:Liver Neoplasms / Q000235:genetics* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D020411:Oligonucleotide Array Sequence Analysis; D051575:Proto-Oncogene Proteins c-yes / Q000235:genetics*
chemical_list: D000912:Antibodies, Neoplasm; D051575:Proto-Oncogene Proteins c-yes; C489834:YES1 protein, human